These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 15466262

  • 1. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
    Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T.
    J Am Soc Nephrol; 2004 Oct; 15(10):2579-87. PubMed ID: 15466262
    [Abstract] [Full Text] [Related]

  • 2. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.
    Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H, Nagano N.
    J Clin Invest; 1997 Dec 15; 100(12):2977-83. PubMed ID: 9399943
    [Abstract] [Full Text] [Related]

  • 3. Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism.
    Wada M, Nagano N, Furuya Y, Chin J, Nemeth EF, Fox J.
    Kidney Int; 2000 Jan 15; 57(1):50-8. PubMed ID: 10620187
    [Abstract] [Full Text] [Related]

  • 4. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
    Nagano N, Nemeth EF.
    J Pharmacol Sci; 2005 Mar 15; 97(3):355-60. PubMed ID: 15781990
    [Abstract] [Full Text] [Related]

  • 5. Prevention of uremic bone disease using calcimimetic compounds.
    Olgaard K, Lewin E.
    Annu Rev Med; 2001 Mar 15; 52():203-20. PubMed ID: 11160775
    [Abstract] [Full Text] [Related]

  • 6. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
    Henley C, Yang Y, Davis J, Lu JY, Morony S, Fan W, Florio M, Sun B, Shatzen E, Pretorius JK, Richards WG, St Jean DJ, Fotsch C, Reagan JD.
    J Pharmacol Exp Ther; 2011 Jun 15; 337(3):681-91. PubMed ID: 21422163
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism.
    Nagano N.
    Pharmacol Ther; 2006 Mar 15; 109(3):339-65. PubMed ID: 16102839
    [Abstract] [Full Text] [Related]

  • 8. [Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics].
    Mizobuchi M, Saji F, Shiizaki K, Sato T, Shibata M, Negi S, Akizawa T, Hatamura I, Ogata H, Kinugasa E.
    Clin Calcium; 2005 Sep 15; 15 Suppl 1():56-8; discussion 58-9. PubMed ID: 16272631
    [Abstract] [Full Text] [Related]

  • 9. Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats.
    Piecha G, Kokeny G, Nakagawa K, Koleganova N, Geldyyev A, Berger I, Ritz E, Schmitt CP, Gross ML.
    Am J Physiol Renal Physiol; 2008 Apr 15; 294(4):F748-57. PubMed ID: 18199601
    [Abstract] [Full Text] [Related]

  • 10. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
    Brown AJ, Ritter CS, Finch JL, Slatopolsky EA.
    Kidney Int; 1999 Apr 15; 55(4):1284-92. PubMed ID: 10200992
    [Abstract] [Full Text] [Related]

  • 11. Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells.
    Mizobuchi M, Ogata H, Hatamura I, Saji F, Koiwa F, Kinugasa E, Koshikawa S, Akizawa T.
    Biochem Biophys Res Commun; 2007 Oct 12; 362(1):11-16. PubMed ID: 17706605
    [Abstract] [Full Text] [Related]

  • 12. [Calcimimetics, mechanisms of action and therapeutic applications].
    Ureña P, Legoupil N, de Vernejoul MC.
    Presse Med; 2005 Sep 10; 34(15):1095-100. PubMed ID: 16334889
    [Abstract] [Full Text] [Related]

  • 13. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
    Rodriguez ME, Almaden Y, Cañadillas S, Canalejo A, Siendones E, Lopez I, Aguilera-Tejero E, Martin D, Rodriguez M.
    Am J Physiol Renal Physiol; 2007 May 10; 292(5):F1390-5. PubMed ID: 17200160
    [Abstract] [Full Text] [Related]

  • 14. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr 10; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 15. The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism.
    Fox J, Lowe SH, Conklin RL, Nemeth EF.
    Endocrine; 1999 Apr 10; 10(2):97-103. PubMed ID: 10451217
    [Abstract] [Full Text] [Related]

  • 16. Calcium-sensing receptor and calcimimetic agents.
    Coburn JW, Elangovan L, Goodman WG, Frazaõ JM.
    Kidney Int Suppl; 1999 Dec 10; 73():S52-8. PubMed ID: 10633465
    [Abstract] [Full Text] [Related]

  • 17. Modulation and action of the calcium-sensing receptor.
    Drüeke TB.
    Nephrol Dial Transplant; 2004 Aug 10; 19 Suppl 5():V20-26. PubMed ID: 15284356
    [Abstract] [Full Text] [Related]

  • 18. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium.
    Fox J, Lowe SH, Petty BA, Nemeth EF.
    J Pharmacol Exp Ther; 1999 Aug 10; 290(2):473-9. PubMed ID: 10411552
    [Abstract] [Full Text] [Related]

  • 19. Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3.
    Rogers KV, Dunn CK, Conklin RL, Hadfield S, Petty BA, Brown EM, Hebert SC, Nemeth EF, Fox J.
    Endocrinology; 1995 Feb 10; 136(2):499-504. PubMed ID: 7835282
    [Abstract] [Full Text] [Related]

  • 20. Calcimimetics with potent and selective activity on the parathyroid calcium receptor.
    Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, Balandrin MF.
    Proc Natl Acad Sci U S A; 1998 Mar 31; 95(7):4040-5. PubMed ID: 9520489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.